Skip to main content
SpringerLink
Log in

Ledipasvir/sofosbuvir

Ventricular tachycardia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kanda T, et al. Successful retreatment of 12-week combination regimen of grazoprevir and elbasvir for HCV GT1b patient, who failed to be treated by sofosbuvir/ledipasvir due to ventricular tachycardia. Hepatology International 12 (Suppl. 2): S548 abstr. HCV-147, Mar 2018. Available from: URL: http://doi.org/10.1007/s12072-018-9852-3 [abstract] - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ledipasvir/sofosbuvir. Reactions Weekly 1697, 223 (2018). https://doi.org/10.1007/s40278-018-44779-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44779-9

Search

Navigation